• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国政府科技报告 >Early Versus Late Recombinant Factor VIIa in Combat Trauma Patients Requiring Massive Transfusion.
【24h】

Early Versus Late Recombinant Factor VIIa in Combat Trauma Patients Requiring Massive Transfusion.

机译：早期与晚期重组因子VIIa在需要大量输血的战斗创伤患者中。

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: Coagulopathy is a consequence of severe trauma, especially in massively transfused patients (greater than 10 units of red blood cells in 24 hours), and is associated with increased mortality. We hypothesized that recombinant factor VIIa (rFVIIa) administered to massive transfusion patients before transfusion of 8 units of blood (early) would reduce transfusion requirements compared with rFVIIa after 8 units (late). Methods: We retrospectively reviewed records for trauma admissions to combat support hospitals in Iraq between January 2004 and October 2005. Patients requiring a massive transfusion and receiving rFVIIa were identified. Groups were divided into those who received rFVIIa early or late. Results: Of 5,334 trauma patients (civilian and military), 365 (6.8%) required massive transfusion. Of these, 117 (32%) received rFVIIa. Complete records for blood transfusions were available for 61 patients: 90% had penetrating trauma, 17 received rFVIIa early, and 44 received it late. At admission, temperature, heart rate, blood pressure, Glasgow Coma Scale score, base deficit, hemoglobin, platelets, prothrombin time/International Normalized Ratio, and Injury Severity Score were similar in both groups as were administered units of fresh frozen plasma, fresh whole blood, cryoprecipitate (cryo), and crystalloid. The early rFVIIa group required fewer units of blood during the first 24-hour period (mean 20.6 vs. 25.7, p = 0.048) and fewer units of stored red blood cells (mean 16.7 vs. 21.7, p = 0.049). Early and late mortality (33.3% vs. 34.2%, p = NS), acute respiratory distress syndrome (5.9 vs. 6.8%, p = NS), infection (5.9% vs. 9.1%, p = NS), and thrombotic events (0% vs. 2.3%, p = NS) were similar. Conclusions: Early administration of rFVIIa decreased red blood cell use by 20% in trauma patients requiring massive transfusion.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号